Background: Adolescent bullying victimisation and maltreatment have been linked to mental health disorders. Early intervention interrupting victimisation continuity is required since adolescence is a critical period for the formation of adult skills. We investigate the protective factors against youth victimisation at school and domestically.
Method: This study uses the youth self-completion questionnaire (preadolescents/adolescents aged 10-15) from the UK Household Longitudinal Study (UKHLS) containing youth victimisation questions in waves 1, 3 and 5 spanning 2009-2013. The self-reported victimisation measures include direct aggression (physical, verbal) and indirect bullying by other young people at school/non-domestically and at the household. The investigation employs balanced and unbalanced sample designs, complete case analysis (CCA) and multiple imputation (MI).
Results: The most effective protective factor reducing victimisation at school and domestically is the strength of family support as felt by the child (perceived family support) and the quality of the family environment. The unobserved factors increasing non-domestic victimisation are related to the latent factors reducing family support. This indicates that victimised adolescents do not always inform their families. The intensity of past period bullying is a strong predictor of future victimisation.
Conclusions: The importance of family support and the quality of the family environment as protective factors necessitates parental involvement in school anti-bullying programmes. The longitudinal persistence of bullying indicates the inability of frequently bullied adolescents to escape victimisation. Anti-bullying policy design should encourage victims to speak up by lowering victimisation stigma and, provide assurances against bully retaliation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.socscimed.2020.112942 | DOI Listing |
Epidemiol Serv Saude
January 2025
Universidade de São Paulo, Escola de Enfermagem de Ribeirão Preto, SP, Brasil.
Objective: To analyze the social network of mothers, fathers or guardians of transgender children or adolescents.
Methods: This was a qualitative study, based on the theoretical framework of social network, with a focus on the primary network. The study was conducted in Brazil through online interviews between August and October 2021.
Rev Gaucha Enferm
January 2025
Universidade Federal de São Paulo, Escola Paulista de Enfermagem, São Paulo, São Paulo, Brasil.
Objective: To analyze family dynamics, the support network of family caregivers of individuals with progressive cancer, and their needs for comprehensive care.
Method: Qualitative, descriptive study developed based on the Calgary Family Assessment Model framework. It was conducted from September 2022 to April 2023, through participant observation at a public health institution in São Paulo and interviews with six family caregivers.
Rev Gaucha Enferm
January 2025
Universidade Federal de São João del-Rei (UFSJ), Faculdade de Enfermagem, Programa de Pós-Graduação em Enfermagem. Divinópolis, Minas Gerais, Brasil.
Objective: To understand the relationships that promote and threaten family hope during pregnancy and in the care of high-risk newborns.
Method: Qualitative research, guided by the theoretical framework of Understanding the Complex Nature of Hope, carried out between December 2021 and March 2022, with 28 members of 14 families attended at a multidisciplinary outpatient clinic for at-risk newborns in Minas Gerais, Brazil. Data obtained from interviews in thematic oral history allowed the construction of narratives, genograms and ecomaps, which were subjected to deductive thematic analysis procedures.
Rev Gaucha Enferm
January 2025
Universidade Federal do Pará. Belém. Pará. Brasil.
Objective: to describe the perception of health professionals and managers in the prison system regarding the continuity of breastfeeding care for lactating women deprived of liberty.
Method: descriptive-exploratory research, qualitative approach, developed in a prison unit in Rio de Janeiro from December 2022 to January 2023. Interviewees: five health professionals and two managers.
J Acquir Immune Defic Syndr
November 2024
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA.
Background: Limited data exist on bictegravir pharmacokinetics in pregnancy among persons with HIV (PWH) and infant washout.
Setting: Nonrandomized, open-label, multi-center phase-IV prospective study of bictegravir pharmacokinetics and safety in pregnant PWH and their infants.
Methods: Steady-state 24-hour pharmacokinetic sampling of oral bictegravir 50 mg once daily (a component of fixed-dose combination bictegravir/emtricitabine/tenofovir alafenamide) during the 2nd and 3rd trimesters and postpartum was performed.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!